The oncogenic fusion gene BCR-ABL results from the reciprocal translocation t(9;22)(q34;q22) characteristic for chronic myeloid leukemia (CML) and BCR-ABL-positive acute lymphoblastic leukemia (ALL). Here, BCR is linked to acute lymphoblastic leukemia.